サンプル依頼リスト カート
  • English
  • Korean
市場調査レポート
商品コード
1455869

マイクロアレイ解析の世界市場：世界および地域別分析- 製品別、タイプ別、用途別、エンドユーザー別、地域別、競合情勢 - 分析と予測 (2023-2033年)

Global Microarray Analysis Market - A Global and Regional Analysis: Focus on Product, Type, Application, End User, Region, Country Level Analysis and Competitive Landscape - Analysis and Forecast, 2023-2033

出版日
発行
BIS Research
ページ情報
英文
納期
1～5営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=149.35円
マイクロアレイ解析の世界市場：世界および地域別分析- 製品別、タイプ別、用途別、エンドユーザー別、地域別、競合情勢 - 分析と予測 (2023-2033年)
出版日: 2024年03月28日
発行: BIS Research
ページ情報: 英文
納期: 1～5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のマイクロアレイ解析の市場規模は、2023年は53億5,790万米ドルから、予測期間中はCAGR 6.56%で推移し、2033年には101億1,240万米ドルに達すると予測されています。

この成長は、ゲノミクスプロジェクト数の増加、薬剤スクリーニングにおけるマイクロアレイ技術の使用、癌のスクリーニングにおけるマイクロアレイ技術の採用増加などに起因しています。この市場には、さまざまな消耗品、機器、ソフトウェア、サービスが含まれます。

市場ライフサイクルステージ

主要市場統計
予測期間 2023-2033年
2023年評価額 53億5,000万米ドル
2033年予測 101億1,000万米ドル
CAGR 6.56%

製品別では、消耗品の部門が市場を独占：

製品別では、消耗品の部門が2022年の市場を独占しました。このカテゴリーには、試薬、キット、アレイプレートなどが含まれ、これらはマイクロアレイプロセスに不可欠であり、サンプルの調製、処理、分析を容易にします。これらの消耗品は使い切りタイプであるため繰り返し必要とされ、サプライヤーにとっては継続的な収益源であり、研究やイノベーションの焦点となっています。これらの消耗品の進歩は、マイクロアレイ検査の効率、信頼性、スループットを向上させ、研究および臨床の両分野での採用をさらに促進することを目的としています。疾患診断から創薬まで、幅広い用途で極めて重要な役割を果たす消耗品は、マイクロアレイ技術の日常的な運用に不可欠であるため、マイクロアレイ解析市場における優位性を確実なものにしています。

タイプ別では、DNAマイクロアレイが市場で優位を保つ：

タイプ別では、DNAマイクロアレイの部門が2022年に最大のシェアを占めました。DNAマイクロアレイは、ゲノミクス研究における重要な役割により、市場における優位性を維持する構えです。基礎技術として、DNAマイクロアレイは何千もの遺伝子の発現を同時に調べる能力を提供し、それによって遺伝子活性の包括的なスナップショットを提供します。この能力は、基礎的な生物学研究から、疾病診断や個別化医療といった応用分野に至るまで、さまざまな用途において非常に貴重です。DNAマイクロアレイの需要は、遺伝的変異の同定、医薬品開発の補助、バイオマーカー探索の可能性など、その有用性によってさらに高まっています。ゲノミクスの進歩が進み、疾患に対する遺伝的影響の解明が重視されるようになるにつれ、DNAマイクロアレイは研究者や臨床医に好まれる選択肢であり続け、市場での持続的な優位性を確保しています。

当レポートでは、世界のマイクロアレイ解析の市場を調査し、市場概要、主要動向、技術・特許の分析、法規制環境、市場影響因子および市場機会の分析、市場規模の推移・予測、各種区分・地域別の詳細分析、競合情勢、主要企業のプロファイルなどをまとめています。

目次

エグゼクティブサマリー

範囲と定義

第1章 市場

  • 動向：現在および将来の影響評価
    • 主な動向
  • エコシステムの概要：マイクロアレイ解析市場
  • R&Dレビュー
    • 特許出願動向（国・企業別）
  • 規制状況
  • 主要な世界的出来事の影響分析：COVID-19
  • 価格分析
  • 市場力学の概要
    • 市場促進要因
    • 市場抑制要因
    • 市場機会

第2章 用途

  • 用途の分類
  • 用途の概要
    • 用途の概要
    • タイプの概要
    • エンドユーザーの概要
  • 世界のマイクロアレイ解析市場：タイプ別
    • DNAマイクロアレイ
    • タンパク質マイクロアレイ
    • その他
  • 世界のマイクロアレイ解析市場：用途別
    • 臨床診断
    • 創薬とトランスレーショナル研究
    • その他
  • 世界のマイクロアレイ解析市場：エンドユーザー別
    • 製薬・バイオテクノロジー企業
    • 診断ラボ
    • 学術・研究機関
    • その他

第3章 製品

  • 製品の分類
  • 製品概要
  • 製品
    • 市場概要
  • 世界のマイクロアレイ解析市場：製品タイプ別
    • 機器
    • 消耗品
    • ソフトウェア・サービス

第4章 地域

  • 地域概要
  • 促進要因・抑制要因
  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • 中東・アフリカ

第5章 市場：競合ベンチマーキング・企業プロファイル

  • 次なるフロンティア
  • 競合評価
    • Agilent Technologies, Inc.
    • Thermo Fisher Scientific, Inc.
    • Illumina, Inc.
    • Bio-Rad Laboratories, Inc.
    • F. Hoffmann-La Roche Ltd.
    • Merck KGaA
    • Revvity, Inc. (PerkinElmer, Inc.)
    • Arrayit Corporation
    • Danaher Corporation
    • Invitae Corporation
    • Helix OpCo LLC
    • Applied Microarrays LLC (SCHOTT)
    • Microarrays Inc.
    • Win Semiconductors Corp.
    • Akonni Biosystems, Inc.

第6章 調査手法

図表

List of Figures

  • Figure 1: Global Microarray Analysis Market, $Million, 2023, 2026, and 2033
  • Figure 2: Global Microarray Analysis Market (by Region), $Million, 2022, 2026, and 2033
  • Figure 3: Global Microarray Analysis Market (by Application), $Million, 2022, 2026, and 2033
  • Figure 4: Global Microarray Analysis Market (by Type), $Million, 2022, 2026, and 2033
  • Figure 5: Global Microarray Analysis Market (by Product), $Million, 2022, 2026, and 2033
  • Figure 6: Global Microarray Analysis Market (by End User), $Million, 2022, 2026, and 2033
  • Figure 7: Key Industrial Developments in Global Microarray Analysis Market, 2023
  • Figure 8: Opportunities in Genetic Research through AI and Automation
  • Figure 9: Ecosystem Overview of Microarray Analysis Market and Operational Challenges
  • Figure 10: Global Microarray Analysis Market, Patent Analysis (by Country), January 2020-December 2023
  • Figure 11: Global Microarray Analysis Market, Patent Analysis (by Year), January 2020-December 2023
  • Figure 12: Examples of the Key Initiative Related to Genomics
  • Figure 13: Applications of Microarray Analysis Technology in Drug Discovery
  • Figure 14: Microarray vs. RNA Sequencing, NGS, and PCR
  • Figure 15: Pitfalls in Data Analysis due to Lack of Skilled Professionals
  • Figure 16: Key Initiatives Focused on Pharmacogenomics to Improve the Landscape of Precision Medicine
  • Figure 17: Precision Medicine vs. Other Medicine
  • Figure 18: U.S. Microarray Analysis Market, $Million, 2022-2033
  • Figure 19: Canada Microarray Analysis Market, $Million, 2022-2033
  • Figure 20: Germany Microarray Analysis Market, $Million, 2022-2033
  • Figure 21: U.K. Microarray Analysis Market, $Million, 2022-2033
  • Figure 22: France Microarray Analysis Market, $Million, 2022-2033
  • Figure 23: Italy Microarray Analysis Market, $Million, 2022-2033
  • Figure 24: Spain Microarray Analysis Market, $Million, 2022-2033
  • Figure 25: China Microarray Analysis Market, $Million, 2022-2033
  • Figure 26: Japan Microarray Analysis Market, $Million, 2022-2033
  • Figure 27: Australia Microarray Analysis Market, $Million, 2022-2033
  • Figure 28: South Korea Microarray Analysis Market, $Million, 2022-2033
  • Figure 29: Rest-of-Asia-Pacific Microarray Analysis Market, $Million, 2022-2033
  • Figure 30: Brazil Microarray Analysis Market, $Million, 2022-2033
  • Figure 31: Mexico Microarray Analysis Market, $Million, 2022-2033
  • Figure 32: Rest-of-Latin America Microarray Analysis Market, $Million, 2022-2033
  • Figure 33: U.A.E. Microarray Analysis Market, $Million, 2022-2033
  • Figure 34: South Africa Microarray Analysis Market, $Million, 2022-2033
  • Figure 35: Rest-of-Middle East and Africa Microarray Analysis Market, $Million, 2022-2033
  • Figure 36: Strategic Initiatives, 2021-2024
  • Figure 37: Share of Strategic Initiatives, 2021-2024
  • Figure 38: Data Triangulation
  • Figure 39: Top-Down and Bottom-Up Approach
  • Figure 40: Assumptions and Limitations

List of Tables

  • Table 1: Market Snapshot
  • Table 2: Global Microarray Analysis Market, Opportunities
  • Table 3: Key Companies and Technological Advancements, 2022-2023
  • Table 4: Pricing Analysis of Microarray Analysis Products (Instruments and Consumables)
  • Table 5: Impact Analysis of Market Navigating Factors, 2022-2033
  • Table 6: Examples of Arrays Used in Cancer Screening
  • Table 7: Global Microarray Analysis Market, by Application, $Million
  • Table 8: Global Microarray Analysis Market, by Type, $Million
  • Table 9: Global Microarray Analysis Market, by End User, $Million
  • Table 10: Global Microarray Analysis Market (by Product), $Million, 2022-2033
  • Table 11: Global Microarray Analysis Market (by Region), $Million, 2022-2033
  • Table 12: North America Microarray Analysis Market (by Product), $Million, 2022-2033
  • Table 13: North America Microarray Analysis Market (by Type), $Million, 2022-2033
  • Table 14: North America Microarray Analysis Market (by Application), $Million, 2022-2033
  • Table 15: North America Microarray Analysis Market (by End User), $Million, 2022-2033
  • Table 16: U.S. Microarray Analysis Market (by Product), $Million, 2022-2033
  • Table 17: U.S. Microarray Analysis Market (by Type), $Million, 2022-2033
  • Table 18: U.S. Microarray Analysis Market (by Application), $Million, 2022-2033
  • Table 19: U.S. Microarray Analysis Market (by End User), $Million, 2022-2033
  • Table 20: Canada Microarray Analysis Market (by Product), $Million, 2022-2033
  • Table 21: Canada Microarray Analysis Market (by Type), $Million, 2022-2033
  • Table 22: Canada Microarray Analysis Market (by Application), $Million, 2022-2033
  • Table 23: Canada Microarray Analysis Market (by End User), $Million, 2022-2033
  • Table 24: Europe Microarray Analysis Market (by Product), $Million, 2022-2033
  • Table 25: Europe Microarray Analysis Market (by Type), $Million, 2022-2033
  • Table 26: Europe Microarray Analysis Market (by Application), $Million, 2022-2033
  • Table 27: Europe Microarray Analysis Market (by End User), $Million, 2022-2033
  • Table 28: Germany Microarray Analysis Market (by Product), $Million, 2022-2033
  • Table 29: Germany Microarray Analysis Market (by Type), $Million, 2022-2033
  • Table 30: Germany Microarray Analysis Market (by Application), $Million, 2022-2033
  • Table 31: Germany Microarray Analysis Market (by End User), $Million, 2022-2033
  • Table 32: U.K. Microarray Analysis Market (by Product), $Million, 2022-2033
  • Table 33: U.K. Microarray Analysis Market (by Type), $Million, 2022-2033
  • Table 34: U.K. Microarray Analysis Market (by Application), $Million, 2022-2033
  • Table 35: U.K. Microarray Analysis Market (by End User), $Million, 2022-2033
  • Table 36: France Microarray Analysis Market (by Product), $Million, 2022-2033
  • Table 37: France Microarray Analysis Market (by Type), $Million, 2022-2033
  • Table 38: France Microarray Analysis Market (by Application), $Million, 2022-2033
  • Table 39: France Microarray Analysis Market (by End User), $Million, 2022-2033
  • Table 40: Italy Microarray Analysis Market (by Product), $Million, 2022-2033
  • Table 41: Italy Microarray Analysis Market (by Type), $Million, 2022-2033
  • Table 42: Italy Microarray Analysis Market (by Application), $Million, 2022-2033
  • Table 43: Italy Microarray Analysis Market (by End User), $Million, 2022-2033
  • Table 44: Spain Microarray Analysis Market (by Product), $Million, 2022-2033
  • Table 45: Spain Microarray Analysis Market (by Type), $Million, 2022-2033
  • Table 46: Spain Microarray Analysis Market (by Application), $Million, 2022-2033
  • Table 47: Spain Microarray Analysis Market (by End User), $Million, 2022-2033
  • Table 48: Rest-of-Europe Microarray Analysis Market, $Million, 2022-2033
  • Table 49: Rest-of-Europe Microarray Analysis Market (by Product), $Million, 2022-2033
  • Table 50: Rest-of-Europe Microarray Analysis Market (by Type), $Million, 2022-2033
  • Table 51: Rest-of-Europe Microarray Analysis Market (by Application), $Million, 2022-2033
  • Table 52: Rest-of-Europe Microarray Analysis Market (by End User), $Million, 2022-2033
  • Table 53: Asia-Pacific Microarray Analysis Market (by Product), $Million, 2022-2033
  • Table 54: Asia-Pacific Microarray Analysis Market (by Type), $Million, 2022-2033
  • Table 55: Asia-Pacific Microarray Analysis Market (by Application), $Million, 2022-2033
  • Table 56: Asia-Pacific Microarray Analysis Market (by End User), $Million, 2022-2033
  • Table 57: China Microarray Analysis Market (by Product), $Million, 2022-2033
  • Table 58: China Microarray Analysis Market (by Type), $Million, 2022-2033
  • Table 59: China Microarray Analysis Market (by Application), $Million, 2022-2033
  • Table 60: China Microarray Analysis Market (by End User), $Million, 2022-2033
  • Table 61: Japan Microarray Analysis Market (by Product), $Million, 2022-2033
  • Table 62: Japan Microarray Analysis Market (by Type), $Million, 2022-2033
  • Table 63: Japan Microarray Analysis Market (by Application), $Million, 2022-2033
  • Table 64: Japan Microarray Analysis Market (by End User), $Million, 2022-2033
  • Table 65: India Microarray Analysis Market, $Million, 2022-2033
  • Table 66: India Microarray Analysis Market (by Product), $Million, 2022-2033
  • Table 67: India Microarray Analysis Market (by Type), $Million, 2022-2033
  • Table 68: India Microarray Analysis Market (by Application), $Million, 2022-2033
  • Table 69: India Microarray Analysis Market (by End User), $Million, 2022-2033
  • Table 70: Australia Microarray Analysis Market (by Product), $Million, 2022-2033
  • Table 71: Australia Microarray Analysis Market (by Type), $Million, 2022-2033
  • Table 72: Australia Microarray Analysis Market (by Application), $Million, 2022-2033
  • Table 73: Australia Microarray Analysis Market (by End User), $Million, 2022-2033
  • Table 74: South Korea Microarray Analysis Market (by Product), $Million, 2022-2033
  • Table 75: South Korea Microarray Analysis Market (by Type), $Million, 2022-2033
  • Table 76: South Korea Microarray Analysis Market (by Application), $Million, 2022-2033
  • Table 77: South Korea Microarray Analysis Market (by End User), $Million, 2022-2033
  • Table 78: Rest-of-Asia-Pacific Microarray Analysis Market (by Product), $Million, 2022-2033
  • Table 79: Rest-of-Asia-Pacific Microarray Analysis Market (by Type), $Million, 2022-2033
  • Table 80: Rest-of-Asia-Pacific Microarray Analysis Market (by Application), $Million, 2022-2033
  • Table 81: Rest-of-Asia-Pacific Microarray Analysis Market (by End User), $Million, 2022-2033
  • Table 82: Latin America Microarray Analysis Market (by Product), $Million, 2022-2033
  • Table 83: Latin America Microarray Analysis Market (by Type), $Million, 2022-2033
  • Table 84: Latin America Microarray Analysis Market (by Application), $Million, 2022-2033
  • Table 85: Latin America Microarray Analysis Market (by End User), $Million, 2022-2033
  • Table 86: Brazil Microarray Analysis Market (by Product), $Million, 2022-2033
  • Table 87: Brazil Microarray Analysis Market (by Type), $Million, 2022-2033
  • Table 88: Brazil Microarray Analysis Market (by Application), $Million, 2022-2033
  • Table 89: Brazil Microarray Analysis Market (by End User), $Million, 2022-2033
  • Table 90: Mexico Microarray Analysis Market (by Product), $Million, 2022-2033
  • Table 91: Mexico Microarray Analysis Market (by Type), $Million, 2022-2033
  • Table 92: Mexico Microarray Analysis Market (by Application), $Million, 2022-2033
  • Table 93: Mexico Microarray Analysis Market (by End User), $Million, 2022-2033
  • Table 94: Rest-of-the-Latin America Microarray Analysis Market (by Product), $Million, 2022-2033
  • Table 95: Rest-of-the-Latin America Microarray Analysis Market (by Type), $Million, 2022-2033
  • Table 96: Rest-of-the-Latin America Microarray Analysis Market (by Application), $Million, 2022-2033
  • Table 97: Rest-of-the-Latin America Microarray Analysis Market (by End User), $Million, 2022-2033
  • Table 98: Middle East and Africa Microarray Analysis Market (by Product), $Million, 2022-2033
  • Table 99: Middle East and Africa Microarray Analysis Market (by Type), $Million, 2022-2033
  • Table 100: Middle East and Africa Microarray Analysis Market (by Application), $Million, 2022-2033
  • Table 101: Middle East and Africa Microarray Analysis Market (by End User), $Million, 2022-2033
  • Table 102: U.A.E Microarray Analysis Market (by Product), $Million, 2022-2033
  • Table 103: U.A.E Microarray Analysis Market (by Type), $Million, 2022-2033
  • Table 104: U.A.E Microarray Analysis Market (by Application), $Million, 2022-2033
  • Table 105: U.A.E Microarray Analysis Market (by End User), $Million, 2022-2033
  • Table 106: South Africa Microarray Analysis Market (by Product), $Million, 2022-2033
  • Table 107: South Africa Microarray Analysis Market (by Type), $Million, 2022-2033
  • Table 108: South Africa Microarray Analysis Market (by Application), $Million, 2022-2033
  • Table 109: South Africa Microarray Analysis Market (by End User), $Million, 2022-2033
  • Table 110: Rest-of-Middle East and Africa Microarray Analysis Market (by Product), $Million, 2022-2033
  • Table 111: Rest-of-Middle East and Africa Microarray Analysis Market (by Type), $Million, 2022-2033
  • Table 112: Rest-of-Middle East and Africa Microarray Analysis Market (by Application), $Million, 2022-2033
  • Table 113: Rest-of-Middle East and Africa Microarray Analysis Market (by End User), $Million, 2022-2033
  • Table 114: Company Market Share, 2022
目次
Product Code: BHP1901SA

Global Microarray Analysis Market Overview

The global microarray analysis market is projected to experience substantial growth over the forecast period 2023-2033. Moreover, the market value for 2023 was $5,357.9 million and is expected to reach $10,112.4 million by 2023, growing at a CAGR of 6.56% during the forecast period. This growth can be attributed to rising numbers of genomics projects fuelling the growth of microarray analysis market, use of microarray technology in drug screening, increasing adoption of microarray technology in cancer screening. The market includes various consumables, instruments, and software and services.

Market Lifecycle Stage

KEY MARKET STATISTICS
Forecast Period2023 - 2033
2023 Evaluation$5.35 Billion
2033 Forecast$10.11 Billion
CAGR6.56%

The microarray analysis market is currently in a mature stage with a robust growth trajectory, propelled by the rising demand for precision medicine and advancements in genetic and genomic research. The market is characterized by a mix of well-established companies and innovative startups, all competing to offer advanced solutions that cater to the evolving demands of research and diagnostics.

Industry Impact

The global microarray analysis market has a significant impact on the biomedical industry, particularly in genomics and personalized medicine. It has become a pivotal tool for scientists and researchers in understanding gene expression and genetic variations, influencing advancements in disease diagnostics and treatment strategies. The technology has been crucial in the development of targeted therapies and the growing field of precision medicine, allowing for more individualized treatment plans based on genetic profiles. Moreover, microarray analysis contributes to the efficiency of drug discovery processes, making it a cornerstone in the pharmacogenomics sector. Despite its profound impact, the market faces challenges due to the high costs of microarray instruments and analysis, which can limit its accessibility.

The global microarray analysis market continues to drive transformative advancements across industries, with far-reaching implications for human health, and environmental sustainability.

Market Segmentation:

Segmentation 1: by Product Type

  • Instruments
  • Consumables
  • Software and Services

Consumables to Dominate the Global Microarray Analysis Market (by Product)

Based on product, the consumables segment dominated the global microarray analysis market in FY2022. This category includes reagents, kits, and array plates, which are integral to the microarray process, facilitating the preparation, processing, and analysis of samples. The recurring need for these consumables due to their single-use nature makes them a continuous source of revenue for suppliers and a focal point for research and innovation. Advances in these consumables aim to increase the efficiency, reliability, and throughput of microarray testing, further driving their adoption in both research and clinical settings. Their pivotal role in a wide array of applications, from disease diagnosis to drug discovery, ensures their dominance in the microarray analysis market as they are essential for the daily operation of microarray technologies.

Segmentation 2: by Type

  • DNA Microarray
  • Protein Microarray
  • Other Microarray

DNA Microarray to Hold its Dominance in the Global Microarray Analysis Market (by Type)

Based on technology, DNA microarray segment accounted for the largest share of the global microarray analysis market in FY2022. DNA microarrays are poised to maintain their dominance in the global microarray analysis market due to their critical role in genomics research. As a cornerstone technology, DNA microarrays offer the ability to simultaneously examine the expression of thousands of genes, thereby providing a comprehensive snapshot of gene activity. This capability is invaluable in a range of applications, from basic biological research to the more applied sectors of disease diagnostics and personalized medicine. The demand for DNA microarrays is further bolstered by their utility in identifying genetic variations, aiding in drug development, and enabling biomarker discovery. With the ongoing advancements in genomics and the increased emphasis on understanding genetic influences on diseases, DNA microarrays continue to be a preferred choice for researchers and clinicians, ensuring their sustained prominence in the market.

Segmentation 3: by Application

  • Clinical Diagnostics
  • Drug Discovery and Translational Research
  • Others

Drug Discovery and Translational Research Procedure to Hold its Dominance in the Global Microarray Analysis Market (by Application)

Based on application, the drug discovery and translational research accounted for the largest share of the global microarray analysis market in FY2022 primarily due mainly due to the increasing prevalence of cancer and the subsequent rise in research activities to understand and combat the disease. Microarray analysis has been crucial in cancer research, aiding in the identification of gene expressions and mutations which are vital for understanding cancer mechanisms and developing effective treatments.

Segmentation 4: by End User

  • Pharmaceutical and Biotechnology Companies
  • Diagnostic Laboratories
  • Academic and Research Institutes
  • Others

Academic and Research Institutes to Hold its Dominance in the Global Microarray Analysis Market (by End User)

Based on end user, the academic and research institutes accounted for the largest share of the global microarray analysis market in FY2022 due to their extensive use of microarray analysis in drug discovery, development, and personalized medicine applications.

Segmentation 5: by Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

Recent Developments in the Global Microarray Analysis Market

  • In January 2024, Thermo Fisher Scientific, Inc. introduced the Axiom PangenomiX Array, its most expansive and culturally diverse array yet which provides enhanced genetic coverage for large-scale disease studies and pharmacogenomic investigations.
  • In August 2023, Thermo Fisher Scientific, Inc. launched a novel chromosomal microarray aimed at enhancing productivity, efficiency, and profitability in cytogenetic research laboratories boasting an industry-leading turnaround time of just two days
  • In March 2023, Microarrays Inc and Alimetrix were acquired by Spectrum Solutions for expansion of laboratory products and testing capabilities.

Demand - Drivers, Restraints, and Opportunities

Market Demand Drivers:

Rising Numbers of Genomics Projects Fueling the Growth of Microarray Analysis Market: The surge in genomics projects globally is a key driver for the expansion of the microarray analysis market. As researchers and scientists undertake more comprehensive studies in genetics, including population genomics, disease research, and personalized medicine, the demand for microarray technologies for analysing gene expressions and variations increases. This trend underscores the crucial role of microarray analysis in facilitating advanced genomic research and discoveries.

Market Restraints:

Competition from Alternative Technologies (NGS): The microarray analysis market faces competition from alternative technologies, particularly next-generation sequencing (NGS). NGS offers advantages such as higher throughput, increased sensitivity, and the ability to detect novel variants. As NGS technology continues to evolve and become more cost-effective, it poses a significant threat to the market share of microarray analysis.

Market Opportunities:

Novel Biomarker Discovery with the Use of Microarray Technology: There is a growing interest of researchers in using this information to inform healthcare decisions, including medication choices. These are tests that are specifically designed to identify patients who are most likely to benefit from a particular drug, based on their genetic profile. By identifying the patients which patients are expected to respond to a particular treatment, companion diagnostics can improve the efficiency of clinical trials and increase the chances of successful drug development.

How can this report add value to an organization?

Workflow/Innovation Strategy: The global microarray analysis market (by product) has been segmented into detailed segments, including different types of consumables, such as arrays, kits and reagents, and accessories as well as instruments, and software and services.

Growth/Marketing Strategy: A strategic growth and marketing approach for the microarray analysis market would involve positioning the company as a leader in innovative solutions that address the evolving needs of researchers, clinicians, and pharmaceutical partners. This would entail leveraging technological advancements to develop cutting-edge products with enhanced sensitivity, specificity, and scalability, while also investing in comprehensive customer support, training programs, and collaborative partnerships to foster customer loyalty and drive market penetration.

Competitive Strategy: Key players in the global microarray analysis market have been focusing on innovation, differentiation, and strategic collaborations to gain a competitive edge. By investing in research and development, companies can develop novel detection methods, improve assay sensitivity, and expand application areas. Differentiation through the development of proprietary technologies, customizable solutions, and value-added services can help companies stand out in a crowded market. to strengthen market positions, acquire new technologies, and broaden product portfolios.

Methodology

Key Considerations and Assumptions in Market Engineering and Validation

  • The base year considered for the calculation of the market size is 2022. The historical year analysis has been done from FY2020 to FY2021, and the market size has been calculated for FY2022 and projected for the period 2023-2033.
  • The geographical distribution of the market revenue has been estimated to be the same as the company's net revenue distribution. All the numbers have been adjusted to two digits after decimals for report presentation reasons. However, the real figures have been utilized for compound annual growth rate (CAGR) estimation. CAGR is calculated from 2023 to 2033.
  • The market has been mapped based on different types of products available in the market and based on several indications. All the key manufacturing companies that have a significant number of offerings to the global microarray analysis market have been considered and profiled in the report.
  • In the study, the primary respondent's verification has been considered to finalize the estimated market for the global microarray analysis market .
  • The latest annual reports of each market player have been taken into consideration for market revenue calculation.
  • Market strategies and developments of key players have been considered for the calculation of sub-segment split.
  • The base currency considered for the market analysis is US$. Currencies other than the US$ have been converted to the US$ for all statistical calculations, considering the average conversion rate for that particular year. The currency conversion rate has been taken from the historical exchange rate of the Oanda website or from the annual reports of the respective company if stated.

Primary Research

The key data points taken from the primary sources include:

  • Validation and triangulation of all the numbers and graphs
  • Validation of the report's segmentation and key qualitative findings
  • Understanding of the numbers of the various markets for market type
  • Percentage split of individual markets for regional analysis

Secondary Research

Open Sources

  • National Center for Biotechnology Information (NCBI), PubMed, Science Direct, World Bank Group, and World Health Organization (WHO)
  • Annual reports, SEC filings, and investor presentations of the leading market players
  • Company websites and detailed study of their portfolio
  • Gold standard magazines, journals, whitepapers, press releases, and news articles
  • Databases

The key data points taken from the secondary sources include:

  • Segmentations, split-ups, and percentage shares
  • Data for market value
  • Key industry trends of the top players in the market
  • Qualitative insights into various aspects of the market, key trends, and emerging areas of innovation
  • Quantitative data for mathematical and statistical calculations

Key Market Players and Competition Synopsis

In the microarray analysis market, several key players dominate the landscape with their diverse range of products and solutions. Thermo Fisher Scientific, Illumina, Inc. Agilent Technologies, Inc., F. Hoffmann-La Roche Ltd, and Merck KGaA are among the prominent market players offering innovative tools and platforms for microarray analysis. These companies provide instruments, consumables, and software and services, to researchers and clinicians worldwide.

The competition in the microarray analysis market is characterized by a dynamic and intensely competitive landscape with a variety of market players. This competition is fuelled by the increasing demand for personalized medicine, advancements in genomic research, and the prevalence of chronic diseases. DNA microarrays are the dominant segment in the market due to their wide adoption in genomics research and their role as a key tool for gene expression profiling and genetic variation detection. Protein microarrays, however, are the fastest-growing segment, gaining ground due to their increasing applications in proteomics research and protein-protein interaction studies.

Some of the prominent companies in this market are:

  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • Illumina, Inc.
  • Bio-Rad Laboratories, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Arrayit Corporation
  • Invitae Corporation
  • Helix OpCo LLC
  • Merck KGaA
  • Applied Microarrays LLC
  • Microarrays Inc.
  • Revvity, Inc. (PerkinElmer, Inc.)
  • Win Semiconductors Corp
  • Akonni Biosystems, Inc.

Companies that are not a part of the aforementioned pool have been well represented across different sections of the report (wherever applicable).

Table of Contents

Executive Summary

Scope and Definition

1 Markets

  • 1.1 Trends: Current and Future Impact Assessment
    • 1.1.1 Key Trends
      • 1.1.1.1 Technological Advancements in Microarray Analysis
      • 1.1.1.2 Developing Focus on Automation and Artificial Intelligence Integration in Microarray Analysis
  • 1.2 Ecosystem Overview: Microarray Analysis Market
    • 1.2.1 Value Addition Across the Process
  • 1.3 Research and Development Review
    • 1.3.1 Patent Filing Trend (by Country, Company)
  • 1.4 Regulatory Landscape
  • 1.5 Impact Analysis for Key Global Events - COVID-19
  • 1.6 Pricing Analysis
  • 1.7 Market Dynamics Overview
    • 1.7.1 Market Drivers
      • 1.7.1.1 Rising Numbers of Genomics Projects Fuelling the Growth of Microarray Analysis Market
      • 1.7.1.2 Use of Microarray Technology in Drug Discovery
      • 1.7.1.3 Increasing Adoption of Microarray Technology in Cancer Screening
    • 1.7.2 Market Restraints
      • 1.7.2.1 Competition from Alternative Technologies such as NGS
      • 1.7.2.2 Challenges in Complex Data Analysis due to Lack of Skilled Professionals
    • 1.7.3 Market Opportunities
      • 1.7.3.1 Novel Biomarker Discovery with the Use of Microarray Technology
      • 1.7.3.2 Utilization of Predictive Genomics for the Development of Personalized Medicines

2 Application

  • 2.1 Application Segmentation
  • 2.2 Application Summary
    • 2.2.1 Application Summary
    • 2.2.2 Type Summary
    • 2.2.3 End User Summary
  • 2.3 Global Microarray Analysis Market (by Type)
    • 2.3.1 DNA Microarray
    • 2.3.2 Protein Microarray
    • 2.3.3 Other Microarray
  • 2.4 Global Microarray Analysis Market (by Application)
    • 2.4.1 Clinical Diagnostics
    • 2.4.2 Drug Discovery and Translational Research
    • 2.4.3 Other Applications
  • 2.5 Global Microarray Analysis Market (by End User)
    • 2.5.1 Pharmaceutical and Biotechnology Companies
    • 2.5.2 Diagnostic Laboratories
    • 2.5.3 Academic and Research Institutes
    • 2.5.4 Others

3 Products

  • 3.1 Product Segmentation
  • 3.2 Product Summary
  • 3.3 Product
    • 3.3.1 Market Overview
      • 3.3.1.1 Analyst View
  • 3.4 Global Microarray Analysis Market (by Product Type)
    • 3.4.1 Instruments
    • 3.4.2 Consumables
    • 3.4.3 Software and Services

4 Regions

  • 4.1 Regional Summary
  • 4.2 Drivers and Restraints
  • 4.3 North America
    • 4.3.1 Regional Overview
    • 4.3.2 Driving Factors for Market Growth
    • 4.3.3 Factors Challenging the Market
    • 4.3.4 U.S.
    • 4.3.5 Canada
  • 4.4 Europe
    • 4.4.1 Regional Overview
    • 4.4.2 Driving Factors for Market Growth
    • 4.4.3 Factors Challenging the Market
    • 4.4.4 Germany
    • 4.4.5 U.K.
    • 4.4.6 France
    • 4.4.7 Italy
    • 4.4.8 Spain
    • 4.4.9 Rest-of-Europe
  • 4.5 Asia-Pacific
    • 4.5.1 Regional Overview
    • 4.5.2 Driving Factors for Market Growth
    • 4.5.3 Factors Challenging the Market
    • 4.5.4 China
    • 4.5.5 Japan
    • 4.5.6 India
    • 4.5.7 Australia
    • 4.5.8 South Korea
    • 4.5.9 Rest-of-Asia-Pacific
  • 4.6 Latin America
    • 4.6.1 Regional Overview
    • 4.6.2 Driving Factors for Market Growth
    • 4.6.3 Factors Challenging the Market
    • 4.6.4 Brazil
    • 4.6.5 Mexico
    • 4.6.6 Rest-of-Latin America
  • 4.7 Middle East and Africa
    • 4.7.1 Regional Overview
    • 4.7.2 Driving Factors for Market Growth
    • 4.7.3 Factors Challenging the Market
    • 4.7.4 U.A.E.
    • 4.7.5 South Africa
    • 4.7.6 Rest-of-Middle East and Africa

5 Markets - Competitive Benchmarking & Company Profiles

  • 5.1 Next Frontiers
  • 5.2 Competitive Assessment
    • 5.2.1 Agilent Technologies, Inc.
      • 5.2.1.1 Overview
      • 5.2.1.2 Top Products/Product Portfolio
      • 5.2.1.3 Top Competitors
      • 5.2.1.4 Key Personnel
      • 5.2.1.5 Analyst View
    • 5.2.2 Thermo Fisher Scientific, Inc.
      • 5.2.2.1 Overview
      • 5.2.2.2 Top Products/Product Portfolio
      • 5.2.2.3 Top Competitors
      • 5.2.2.4 Key Personnel
      • 5.2.2.5 Analyst View
    • 5.2.3 Illumina, Inc.
      • 5.2.3.1 Overview
      • 5.2.3.2 Top Products/Product Portfolio
      • 5.2.3.3 Top Competitors
      • 5.2.3.4 Key Personnel
      • 5.2.3.5 Analyst View
    • 5.2.4 Bio-Rad Laboratories, Inc.
      • 5.2.4.1 Overview
      • 5.2.4.2 Top Products/Product Portfolio
      • 5.2.4.3 Top Competitors
      • 5.2.4.4 Key Personnel
      • 5.2.4.5 Analyst View
    • 5.2.5 F. Hoffmann-La Roche Ltd.
      • 5.2.5.1 Overview
      • 5.2.5.2 Top Products/Product Portfolio
      • 5.2.5.3 Top Competitors
      • 5.2.5.4 Key Personnel
      • 5.2.5.5 Analyst View
    • 5.2.6 Merck KGaA
      • 5.2.6.1 Overview
      • 5.2.6.2 Top Products/Product Portfolio
      • 5.2.6.3 Top Competitors
      • 5.2.6.4 Key Personnel
      • 5.2.6.5 Analyst View
    • 5.2.7 Revvity, Inc. (PerkinElmer, Inc.)
      • 5.2.7.1 Overview
      • 5.2.7.2 Top Products/Product Portfolio
      • 5.2.7.3 Top Competitors
      • 5.2.7.4 Key Personnel
      • 5.2.7.5 Analyst View
    • 5.2.8 Arrayit Corporation
      • 5.2.8.1 Overview
      • 5.2.8.2 Top Products/Product Portfolio
      • 5.2.8.3 Top Competitors
      • 5.2.8.4 Key Personnel
      • 5.2.8.5 Analyst View
    • 5.2.9 Danaher Corporation
      • 5.2.9.1 Overview
      • 5.2.9.2 Top Products
      • 5.2.9.3 Top Competitors
      • 5.2.9.4 Key Personnel
      • 5.2.9.5 Analyst View
    • 5.2.10 Invitae Corporation
      • 5.2.10.1 Overview
      • 5.2.10.2 Top Products/Product Portfolio
      • 5.2.10.3 Top Competitors
      • 5.2.10.4 Key Personnel
      • 5.2.10.5 Analyst View
    • 5.2.11 Helix OpCo LLC
      • 5.2.11.1 Overview
      • 5.2.11.2 Top Products/Product Portfolio
      • 5.2.11.3 Top Competitors
      • 5.2.11.4 Key Personnel
      • 5.2.11.5 Analyst View
    • 5.2.12 Applied Microarrays LLC (SCHOTT)
      • 5.2.12.1 Overview
      • 5.2.12.2 Top Products/Product Portfolio
      • 5.2.12.3 Top Competitors
      • 5.2.12.4 Key Personnel
      • 5.2.12.5 Analyst View
    • 5.2.13 Microarrays Inc.
      • 5.2.13.1 Overview
      • 5.2.13.2 Top Products/Product Portfolio
      • 5.2.13.3 Top Competitors
      • 5.2.13.4 Key Personnel
      • 5.2.13.5 Analyst View
    • 5.2.14 Win Semiconductors Corp.
      • 5.2.14.1 Overview
      • 5.2.14.2 Top Products
      • 5.2.14.3 Top Competitors
      • 5.2.14.4 Key Personnel
      • 5.2.14.5 Analyst View
    • 5.2.15 Akonni Biosystems, Inc.
      • 5.2.15.1 Overview
      • 5.2.15.2 Top Products/Product Portfolio
      • 5.2.15.3 Top Competitors
      • 5.2.15.4 Key Personnel
      • 5.2.15.5 Analyst View

6 Research Methodology

  • 6.1 Data Sources
    • 6.1.1 Primary Data Sources
    • 6.1.2 Secondary Data Sources
    • 6.1.3 Data Triangulation
  • 6.2 Market Estimation and Forecast